FDA Advisory Committees To Help Decide Medicare Rx Data Research Agenda
This article was originally published in The Pink Sheet Daily
Executive Summary
Claims data collected on prescriptions filled through the Medicare drug benefit will be used by outside groups to produce evidence on drugs' safety and effectiveness. FDA advisory committees, AHRQ and IoM could help determine study priorities, CMS says.